نتائج البحث

Is there any robust evidence showing that SGLT2 inhibitor predisposes to cancer?

• Authors : Copur S; Department of Medicine, Koc University School of Medicine, Istanbul, Turkey.; Yildiz AB

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/pharmacology ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

• Source: European journal of clinical investigation [Eur J Clin Invest] 2024 Feb; Vol. 54 (2), pp. e14131. Date of Electronic Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362

تفاصيل العنوان

Combination therapy with an SGLT-2 inhibitor and finerenone in DKD: Are we there yet?

• Authors : Georgianos PI; Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.; Eleftheriadis T

Subjects: Sodium-Glucose Transporter 2 Inhibitors* ; Diabetic Nephropathies* ; Diabetes Mellitus, Type 2*

• Source: European journal of clinical investigation [Eur J Clin Invest] 2023 Feb; Vol. 53 (2), pp. e13864. Date of Electronic Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362

تفاصيل العنوان

Recent advances in pharmacological treatment of heart failure.

• Authors : Iacoviello M; Cardiology Unit, Department of Medical and Surgical Science, University of Foggia, Foggia, Italy.; Palazzuoli A

Subjects: Angiotensin Receptor Antagonists/Angiotensin Receptor Antagonists/Angiotensin Receptor Antagonists/*therapeutic use ; Cardiotonic Agents/Cardiotonic Agents/Cardiotonic Agents/*therapeutic use ; Heart Failure/Heart Failure/Heart Failure/*drug therapy

• Source: European journal of clinical investigation [Eur J Clin Invest] 2021 Nov; Vol. 51 (11), pp. e13624. Date of Electronic Publication: 2021 Jun 15.Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362

تفاصيل العنوان

SGLT2 inhibition and COVID-19: The road not taken.

• Authors : Das L; Department of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.; Dutta P

Subjects: COVID-19 Drug Treatment*; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*drug therapy ; Diabetes Mellitus/Diabetes Mellitus/Diabetes Mellitus/*drug therapy

• Source: European journal of clinical investigation [Eur J Clin Invest] 2020 Dec; Vol. 50 (12), pp. e13339. Date of Electronic Publication: 2020 Sep 22.Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362

تفاصيل العنوان

Prognosis of patients eligible for dapagliflozin in acute heart failure.

• Authors : Carballo S; Service of Internal Medicine, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.; Stirnemann J

Subjects: Eligibility Determination* ; Mortality*; Benzhydryl Compounds/Benzhydryl Compounds/Benzhydryl Compounds/*therapeutic use

• Source: European journal of clinical investigation [Eur J Clin Invest] 2020 Jun; Vol. 50 (6), pp. e13245. Date of Electronic Publication: 2020 May 15.Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362

تفاصيل العنوان

Meta‐analysis of factors associated with antidiabetic drug prescribing for type 2 diabetes mellitus.

• Authors : Mahmoud, Fatema¹ (AUTHOR) ; Mullen, Alexander¹ (AUTHOR); Sainsbury, Chris² (AUTHOR)

• Source: European Journal of Clinical Investigation. Aug2023, Vol. 53 Issue 8, p1-29. 29p.

تفاصيل العنوان